FOXO6 (forkhead box protein O6) antibodies are tools used to detect this transcription factor involved in cellular metabolism and muscle differentiation. While no FITC-conjugated versions appear in the provided sources, standard FOXO6 antibodies exhibit these characteristics:
FITC (fluorescein isothiocyanate) conjugation enables direct fluorescence-based detection. Though not explicitly described in the search results, FITC-conjugated antibodies generally follow these protocols:
| Application | Usage |
|---|---|
| Immunofluorescence | Direct visualization of FOXO6 in fixed cells/tissues |
| Flow Cytometry | Quantifying FOXO6 expression in cell populations |
| ELISA | Antigen detection without secondary antibodies |
Despite the absence of FITC-specific data, studies highlight FOXO6’s biological roles:
Muscle Atrophy: FOXO6 knockdown in C2C12 cells reduces myotube differentiation and increases atrophy markers (atrogin1, MURF1) .
Molecular Weight Variability: Discrepancies in observed molecular weights (51–80 kDa) suggest post-translational modifications or isoform-specific detection .
Conjugate Validation: FITC conjugation requires empirical optimization for each application (e.g., WB vs. IF).
Species Compatibility: Confirm cross-reactivity with target species (e.g., rat, human) using validation data.
Phosphorylation States: Phospho-specific antibodies (e.g., ab154832 ) may require distinct validation steps.